RxDoctor Payments Data

Antoinette Deingeniis-Depasquale, DO

Family Medicine · Kinnelon, NJNPI 1922192517

Payments from drug & device makers

$4,527in general payments, 2019–2025

Across 349 payments — averaging $12.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$949
  • Novo Nordisk$645
  • AstraZeneca$437
  • Lilly USA, LLC$267
  • GSK$228
  • Exact Sciences$201
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$4,512100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,527 in reported general payments places this provider in the 85th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$130,542
Medicare patients
597
Services billed
1,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$35,171
EliquisApixaban24$32,026
ArexvyRsvpref3 Antigen/As01e/Pf67$19,484
JardianceEmpagliflozin16$13,715
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,469
Atorvastatin Calcium229$2,326
SynthroidLevothyroxine Sodium24$2,306
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,239
Levothyroxine Sodium249$2,198
Losartan Potassium153$1,949
Metoprolol Succinate120$1,866
Rosuvastatin Calcium136$1,774
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide26$1,254
Omeprazole75$1,125
Pantoprazole Sodium62$1,114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$645$35,17136 claims
PfizerEliquis$151$32,02624 claims
GSKArexvy, Shingrix$228$23,95388 claims
Boehringer IngelheimJardiance$73$13,71516 claims
AbbVieSynthroid$949$2,30624 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$26$2,198249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Kinnelon

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →